Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000226338 is a pseudogene annotated as "pseudogene similar to part of phospholipase C, gamma 1 (PLCG1)"[1][5]. Pseudogenes are genomic DNA sequences similar to normal genes but are nonfunctional; they arise by gene duplication or retrotransposition and typically acquire disabling mutations[2][4]. This entry is not an active protein-coding gene, nor is there evidence it encodes a functional protein or acts as a therapeutic target. While some pseudogenes may have regulatory roles, there is no evidence for such a function here. Since this entry lacks a functional gene product, molecular function, or established disease association, it is inappropriate to consider it a therapeutic target or druggable entity[1][5][2]. Note: This pseudogene is not the functional phospholipase C, gamma 1 protein (PLCG1, ENSG00000124181) but merely shares sequence similarity[1][3][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pseudogene similar to part of phospholipase C, gamma 1.